載入...

Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk

Rivaroxaban is a direct factor Xa inhibitor that is widely available to reduce the risk of stroke or systemic embolism in patients with nonvalvular atrial fibrillation and one or more risk factors for stroke. Rivaroxaban provides practical advantages compared with warfarin and other vitamin K antago...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Haas, Sylvia, Bode, Christoph, Norrving, Bo, Turpie, Alexander GG
格式: Artigo
語言:Inglês
出版: Dove Medical Press 2014
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3956810/
https://ncbi.nlm.nih.gov/pubmed/24648742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S55246
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!